Analysed LEXEO THERAPEUTICS INC (LXEO:NASDAQ) News Sources
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
30-03-2026
yahoo.com
Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference
28-02-2026
marketbeat.com
Lexeo Therapeutics Details FDA Path for LX2006, Highlights LVMI Gains at Guggenheim Biotech Summit
14-02-2026
marketbeat.com
H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program
02-02-2026
yahoo.com
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
27-01-2026
yahoo.com
Lexeo Therapeutics Announces Positive Interim Phase I/II Data for LX2020 for the Treatment of PKP2-Associated Arrhythmogenic Cardiomyopathy
12-01-2026
yahoo.com
What is the current price of LEXEO THERAPEUTICS INC (LXEO:NASDAQ)?
The current price of LEXEO THERAPEUTICS INC (LXEO:NASDAQ) is $5.98.
LEXEO THERAPEUTICS INC (LXEO:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEXEO THERAPEUTICS INC (LXEO:NASDAQ) since the previous trading day is $-0.45.
LEXEO THERAPEUTICS INC (LXEO:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEXEO THERAPEUTICS INC (LXEO:NASDAQ) since the previous trading day is -6.9984%.
What is the most recent average sentiment score for LEXEO THERAPEUTICS INC (LXEO:NASDAQ)?
The most recent average sentiment score for LEXEO THERAPEUTICS INC (LXEO:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for LEXEO THERAPEUTICS INC (LXEO:NASDAQ)?
The most recent sentiment for LEXEO THERAPEUTICS INC (LXEO:NASDAQ) is .
SEC-8K** Filing Available For LEXEO THERAPEUTICS INC (LXEO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.